Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Return on Equity (2016 - 2023)

Historic Return on Equity for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2023 value amounting to 0.03%.

  • Aptevo Therapeutics' Return on Equity fell 100.0% to 0.03% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.03%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.11% for FY2022, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2023, Aptevo Therapeutics' Return on Equity is 0.03%, which was down 100.0% from 0.03% recorded in Q2 2023.
  • Aptevo Therapeutics' 5-year Return on Equity high stood at 0.22% for Q4 2021, and its period low was 1.1% during Q4 2019.
  • Over the past 5 years, Aptevo Therapeutics' median Return on Equity value was 0.02% (recorded in 2020), while the average stood at 0.27%.
  • In the last 5 years, Aptevo Therapeutics' Return on Equity plummeted by -16500bps in 2019 and then soared by 9500bps in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Return on Equity stood at 1.1% in 2019, then surged by 37bps to 0.7% in 2020, then skyrocketed by 132bps to 0.22% in 2021, then plummeted by -73bps to 0.06% in 2022, then plummeted by -44bps to 0.03% in 2023.
  • Its last three reported values are 0.03% in Q3 2023, 0.03% for Q2 2023, and 0.04% during Q1 2023.